Latest News

  • Follow the Money: Discovery Service Expansion, AI-Driven Discovery of Cancer Targets, More

    Diagnostics World | Alloy speeds up growth to deepen its core discovery service in antibodies, genetic medicines, and cell therapies; RyboDyn accelerates transition from foundational discovery into scaled platform execution and progresses early-stage programs into IND-enabling studies; and more.

    Apr 30, 2026

  • AI Framework for Differentiating Neurodegenerative Diseases

    Diagnostics World | A team of computational scientists at Lund University (Sweden) have built a deep, joint-learning proteomics model for improving the diagnostic accuracy for a handful of dementia-related conditions which in primary care settings remains challenging due to a shortage of informative biomarkers. Predicting these different but correlated pathologies together with a single blood test would facilitate a differential diagnosis with speed and confidence.

    Apr 29, 2026

  • Genome Uploaded to Quantum Computer, Cepheid, Oxford Nanopore Partnership Expansion, Biognosys Group, Michael J. Fox Foundation Collaboration

    Diagnostics World | Scientists achieve world first by loading a complete genome onto a quantum computer; Cepheid and Oxford Nanopore announce an expansion of their partnership; Biognosys Group and The Michael J. Fox Foundation for Parkinson’s Research announce a collaboration; and more.

    Apr 28, 2026

  • Mount Sinai and SOPHiA GENETICS Collaborate for Early Cancer and Tumor Detection

    Diagnostics World | Mount Sinai Health System announced that it has adopted SOPHiA DDM, SOPHiA GENETICS’ AI-powered platform that analyzes complex genomic and multimodal data, producing real-time, actionable insights for hospital, laboratory, and biopharma institutions across the world. Mount Sinai’s molecular pathology team will use the SOPHiA DDM for Blood Cancers and SOPHiA DDM for Solid Tumors applications to enhance next-generation sequencing for blood cancers and solid tumors.

    Apr 24, 2026

  • Built-From-Scratch Screening Device Takes Aim at Ovarian Cancer

    Diagnostics World | It is notoriously difficult to detect ovarian cancer early, particularly aggressive high-grade serous types that often originate as precursor lesions in the fallopian tubes. The cancer quietly spreads at a microscopic level within the abdomen, defying discovery until symptoms emerge in advanced stages of the disease when it becomes hard to treat and difficult to cure.

    Apr 22, 2026

  • Walking Patterns May Help Differentiate Between Parkinson’s Disease and Dementia with Lewy Bodies

    Diagnostics World | Early dementia with Lewy bodies (DLB) and early Parkinson’s disease share several symptoms and are often misdiagnosed in early stages. It is critical to accurately distinguish the two diseases because of their contrasting disease paths. Fortunately, walking behaviors may be early diagnostic markers for neurodegeneration.

    Apr 17, 2026

  • Children’s Hospital of Philadelphia and Labcorp Collaborate for Pediatric Diagnosis

    Diagnostics World | Labcorp and the Children’s Hospital of Philadelphia (CHOP) announced this week that they will be entering a collaboration to advance the discovery and development of specialized pediatric diagnostics, as well as expand access to advanced diagnostic testing for children and families across the nation.

    Apr 16, 2026

  • Study Links Executive Functioning to Physical Activity in Older Adults

    Diagnostics World | Researchers in Belgium compared cognition to movement data in healthy adults looking for links that might predict cognitive decline later in life. The study is part of the PASOCA-project (how Physical Activity and Sleep relate to Optimal Cognitive Ageing), a two-year longitudinal, observational study examining 24-hour movement behaviors and cognitive function in cognitively healthy adults aged 55 and older residing in Flanders, Belgium.

    Apr 14, 2026

  • Using Genomics to Tease Apart Racial Disparities in Breast Cancer Outcomes

    Diagnostics World | New research released in pre-print from npj Breast Cancer digs deeper into the racial disparities of breast cancer and how the MammaPrint and BluePrint genomic tests from Agendia handle the differences.

    Apr 10, 2026

  • From Fingertip to Mainstream: Babson Diagnostics Bets Its Decade of Science Is Ready for Prime Time

    Diagnostics World | When Web Golinkin joined Babson Diagnostics as an advisor in mid-2024, he did what experienced healthcare executives do: he listened, watched, and formed a thesis. After eight months advising, a brief stint as president and chief commercial officer, and now one month into the CEO role, his thesis has hardened into conviction.

    Apr 9, 2026

  • The Future of Blood Testing Lies in Understanding the Whole Body

    Diagnostics World | For decades, blood testing innovation has focused on improving patient testing for earlier and faster intervention. Advances in sequencing, automation, and molecular testing have dramatically improved our ability to biologically monitor patients. But as powerful as these technologies have become, they often still operate within a limited framework: they look for a biomarker panel that constitutes a single signal tied to a single disease.

    Apr 3, 2026

  • Handheld AI-Powered Eye Scanner Could Reach More Patients

    Diagnostics World | Research out of Tohoku University in Sendai, Japan, provides a model for easily assessing front of the eye health outside of hospitals. The research team envisions employing the portable AI-powered scanning slit-light device in remote eye-screening camps, elderly-care facilities, pharmacies, or even train stations to make ophthalmic care more accessible, so patients can be assessed any place and any time.

    Apr 2, 2026

  • Roche ApoE4 Blood Test

    Diagnostics World | Roche has received CE Mark approval for its Elecsys Apolipoprotein E4 biomarker test – the first in-vitro diagnostic (IVD) immunoassay to identify the presence of the ApoE4 gene variant in the bloodstream.

    Apr 1, 2026

  • Follow the Money: Precision Genetic Drugs, Engineering Synthetic Macrocyclic Peptides, More

    Diagnostics World | BreezeBio, formerly known as GenEdit, advances their NanoGalaxy delivery platform; Unnatural Products develops their proprietary drug discovery platform; and more.

    Mar 25, 2026

  • Verily, Samsung Collaboration, PathAI Receives FDA Approval, LinusBio Expands Test Further

    Diagnostics World | Verily Life Sciences and Samsung Electronics America enter a collaboration; PathAI announces that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to PathAssist Derm; LinusBio announces that ClearStrand-ASD is now available for children up to age 10; and more.

    Mar 24, 2026

  • Beyond the Breakthrough: What Alzheimer’s Blood Tests Need Before They Can Truly Change Care

    Diagnostics World | The gold standard tests — PET scans that visualize amyloid plaques and cerebral spinal fluid (CSF) assays that measure core biomarkers directly — have long been the backbone of accurate Alzheimer’s diagnoses. Next-generation Alzheimer’s blood-based biomarkers are now producing accuracy levels in the greater than 90% sensitivity range, roughly on par with PET and CSF. This is not just a scientific milestone — it feels like a shift in what is possible for everyday clinical practice.

    Mar 20, 2026

  • Illumina, Labcorp Expand Collaboration, Develop New IVD Tests

    Diagnostics World | Illumina and Labcorp today announced an expanded collaboration to develop applications of next-generation sequencing (NGS) solutions across the healthcare ecosystem. Projects are expected to include distributed cancer biomarker test offerings; generating evidence to facilitate payer coverage; and developing new tests to address areas of unmet need.

    Mar 18, 2026

  • Simple Blood Test Predicts Survival Based on Causal Biomarkers

    Diagnostics World | Aging has increasingly been viewed as a modifiable target for therapeutic intervention, an encouraging idea that was recently reaffirmed with the development of a simple blood test for predicting survival. The biomarkers being measured include five piwi-interacting RNAs, together with high density lipoprotein particle number and the ability to do instrumental activities of daily living, such as the ability to independently shop and do housework.

    Mar 17, 2026

  • Droplet Biosciences Turns Post-Op Waste Into Life-Saving Data

    Diagnostics World |Droplet Bioscience’s validated clinical test analyzes post-surgical lymphatic fluid for circulating tumor DNA. In a process sped up by NVIDIA Parabricks, the test can provide adjuvant-informing results in about a week.

    Mar 11, 2026

  • The GLP-1 Era: It’s More Than Just Weight

    Diagnostics World News | The healthcare industry has a weight problem—a weight bias problem, according to Ashley Koff, RD, founder of The Better Nutrition Program. During her plenary keynote at February’s Integrative Healthcare Symposium, Koff addressed the urgent need to rethink approaches to weight, metabolic health, and the use of GLP-1 medications.

    Mar 10, 2026